Get Real Time Here
| Open3.480 | Close- |
| Vol / Avg.43.900K / 104.815K | Mkt Cap433.510M |
| Day Range3.420 - 3.620 | 52 Wk Range1.500 - 4.650 |
Nautilus Biotechnology Stock (NASDAQ:NAUT), Quotes and News Summary
Nautilus Biotechnology Stock (NASDAQ: NAUT) stock price, news, charts, stock research, profile.
| Open3.480 | Close- |
| Vol / Avg.43.900K / 104.815K | Mkt Cap433.510M |
| Day Range3.420 - 3.620 | 52 Wk Range1.500 - 4.650 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.170 | -0.130 | 0.0400 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-08-03 | Morgan Stanley | Tejas Savant | Reiterates | Equal-WeightEqual-Weight | Maintains | 6.00 | 6.00 |
| 2022-08-03 | Morgan Stanley | Tejas Savant | Maintains | Equal-Weight | Lowers | 8.00 | 6.00 |
| 2022-08-03 | Goldman Sachs | Matthew Sykes | Maintains | Neutral | Lowers | 4.00 | 2.00 |
| 2022-07-14 | Goldman Sachs | Matthew Sykes | Maintains | Neutral | Lowers | 5.00 | 4.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| NAUT | Nautilus Biotechnology | -1.14% | 433.5M |
| HBIO | Harvard Bioscience | 0.49% | 175.9M |
| CDXS | Codexis | -5.29% | 112.4M |
| BLFS | BioLife Solns | 0.12% | 553M |
| OLK | Olink Holding | -0.68% | 1.8B |
How do I buy Nautilus Biotechnology (NAUT) stock?
You can purchase shares of Nautilus Biotechnology (NASDAQ: NAUT) through any online brokerage.
Who are Nautilus Biotechnology's (NAUT) competitors?
Other companies in Nautilus Biotechnology’s space includes: Harvard Bioscience (NASDAQ:HBIO), Codexis (NASDAQ:CDXS), BioLife Solns (NASDAQ:BLFS), Olink Holding (NASDAQ:OLK) and Quanterix (NASDAQ:QTRX).
What is the target price for Nautilus Biotechnology (NAUT) stock?
The latest price target for Nautilus Biotechnology (NASDAQ: NAUT) was reported by Morgan Stanley on Thursday, August 3, 2023. The analyst firm set a price target for 6.00 expecting NAUT to rise to within 12 months (a possible 72.91% upside). 1 analyst firms have reported ratings in the last year.
Current Stock Price for Nautilus Biotechnology (NAUT)?
The stock price for Nautilus Biotechnology (NASDAQ: NAUT) is $3.47 last updated Today at September 21, 2023 at 7:49 PM UTC.
Does Nautilus Biotechnology (NAUT) pay a dividend?
There is no dividend information for Nautilus Biotechnology.
When is Nautilus Biotechnology (NASDAQ:NAUT) reporting earnings?
Nautilus Biotechnology’s Q3 earnings are confirmed for Tuesday, October 31, 2023.
Is Nautilus Biotechnology (NAUT) going to split?
There is no upcoming split for Nautilus Biotechnology.
What sector and industry does Nautilus Biotechnology (NAUT) operate in?
Nautilus Biotechnology is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NASDAQ.
Nautilus Biotechnology Stock (NASDAQ:NAUT), Quotes and News Summary
Nautilus Biotechnology Stock (NASDAQ: NAUT) stock price, news, charts, stock research, profile.
| Open3.480 | Close- |
| Vol / Avg.43.900K / 104.815K | Mkt Cap433.510M |
| Day Range3.420 - 3.620 | 52 Wk Range1.500 - 4.650 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.170 | -0.130 | 0.0400 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-08-03 | Morgan Stanley | Tejas Savant | Reiterates | Equal-WeightEqual-Weight | Maintains | 6.00 | 6.00 |
| 2022-08-03 | Morgan Stanley | Tejas Savant | Maintains | Equal-Weight | Lowers | 8.00 | 6.00 |
| 2022-08-03 | Goldman Sachs | Matthew Sykes | Maintains | Neutral | Lowers | 4.00 | 2.00 |
| 2022-07-14 | Goldman Sachs | Matthew Sykes | Maintains | Neutral | Lowers | 5.00 | 4.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| NAUT | Nautilus Biotechnology | -1.14% | 433.5M |
| HBIO | Harvard Bioscience | 0.49% | 175.9M |
| CDXS | Codexis | -5.29% | 112.4M |
| BLFS | BioLife Solns | 0.12% | 553M |
| OLK | Olink Holding | -0.68% | 1.8B |
How do I buy Nautilus Biotechnology (NAUT) stock?
You can purchase shares of Nautilus Biotechnology (NASDAQ: NAUT) through any online brokerage.
Who are Nautilus Biotechnology's (NAUT) competitors?
Other companies in Nautilus Biotechnology’s space includes: Harvard Bioscience (NASDAQ:HBIO), Codexis (NASDAQ:CDXS), BioLife Solns (NASDAQ:BLFS), Olink Holding (NASDAQ:OLK) and Quanterix (NASDAQ:QTRX).
What is the target price for Nautilus Biotechnology (NAUT) stock?
The latest price target for Nautilus Biotechnology (NASDAQ: NAUT) was reported by Morgan Stanley on Thursday, August 3, 2023. The analyst firm set a price target for 6.00 expecting NAUT to rise to within 12 months (a possible 72.91% upside). 1 analyst firms have reported ratings in the last year.
Current Stock Price for Nautilus Biotechnology (NAUT)?
The stock price for Nautilus Biotechnology (NASDAQ: NAUT) is $3.47 last updated Today at September 21, 2023 at 7:49 PM UTC.
Does Nautilus Biotechnology (NAUT) pay a dividend?
There is no dividend information for Nautilus Biotechnology.
When is Nautilus Biotechnology (NASDAQ:NAUT) reporting earnings?
Nautilus Biotechnology’s Q3 earnings are confirmed for Tuesday, October 31, 2023.
Is Nautilus Biotechnology (NAUT) going to split?
There is no upcoming split for Nautilus Biotechnology.
What sector and industry does Nautilus Biotechnology (NAUT) operate in?
Nautilus Biotechnology is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NASDAQ.
Nautilus Biotechnology Stock (NASDAQ:NAUT), Quotes and News Summary
Nautilus Biotechnology Stock (NASDAQ: NAUT) stock price, news, charts, stock research, profile.
| Open3.480 | Close- |
| Vol / Avg.43.900K / 104.815K | Mkt Cap433.510M |
| Day Range3.420 - 3.620 | 52 Wk Range1.500 - 4.650 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.170 | -0.130 | 0.0400 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-08-03 | Morgan Stanley | Tejas Savant | Reiterates | Equal-WeightEqual-Weight | Maintains | 6.00 | 6.00 |
| 2022-08-03 | Morgan Stanley | Tejas Savant | Maintains | Equal-Weight | Lowers | 8.00 | 6.00 |
| 2022-08-03 | Goldman Sachs | Matthew Sykes | Maintains | Neutral | Lowers | 4.00 | 2.00 |
| 2022-07-14 | Goldman Sachs | Matthew Sykes | Maintains | Neutral | Lowers | 5.00 | 4.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| NAUT | Nautilus Biotechnology | -1.14% | 433.5M |
| HBIO | Harvard Bioscience | 0.49% | 175.9M |
| CDXS | Codexis | -5.29% | 112.4M |
| BLFS | BioLife Solns | 0.12% | 553M |
| OLK | Olink Holding | -0.68% | 1.8B |
How do I buy Nautilus Biotechnology (NAUT) stock?
You can purchase shares of Nautilus Biotechnology (NASDAQ: NAUT) through any online brokerage.
Who are Nautilus Biotechnology's (NAUT) competitors?
Other companies in Nautilus Biotechnology’s space includes: Harvard Bioscience (NASDAQ:HBIO), Codexis (NASDAQ:CDXS), BioLife Solns (NASDAQ:BLFS), Olink Holding (NASDAQ:OLK) and Quanterix (NASDAQ:QTRX).
What is the target price for Nautilus Biotechnology (NAUT) stock?
The latest price target for Nautilus Biotechnology (NASDAQ: NAUT) was reported by Morgan Stanley on Thursday, August 3, 2023. The analyst firm set a price target for 6.00 expecting NAUT to rise to within 12 months (a possible 72.91% upside). 1 analyst firms have reported ratings in the last year.
Current Stock Price for Nautilus Biotechnology (NAUT)?
The stock price for Nautilus Biotechnology (NASDAQ: NAUT) is $3.47 last updated Today at September 21, 2023 at 7:49 PM UTC.
Does Nautilus Biotechnology (NAUT) pay a dividend?
There is no dividend information for Nautilus Biotechnology.
When is Nautilus Biotechnology (NASDAQ:NAUT) reporting earnings?
Nautilus Biotechnology’s Q3 earnings are confirmed for Tuesday, October 31, 2023.
Is Nautilus Biotechnology (NAUT) going to split?
There is no upcoming split for Nautilus Biotechnology.
What sector and industry does Nautilus Biotechnology (NAUT) operate in?
Nautilus Biotechnology is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NASDAQ.
Nautilus Biotechnology Stock (NASDAQ:NAUT), Quotes and News Summary
Nautilus Biotechnology Stock (NASDAQ: NAUT) stock price, news, charts, stock research, profile.
| Open3.480 | Close- |
| Vol / Avg.43.900K / 104.815K | Mkt Cap433.510M |
| Day Range3.420 - 3.620 | 52 Wk Range1.500 - 4.650 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.170 | -0.130 | 0.0400 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-08-03 | Morgan Stanley | Tejas Savant | Reiterates | Equal-WeightEqual-Weight | Maintains | 6.00 | 6.00 |
| 2022-08-03 | Morgan Stanley | Tejas Savant | Maintains | Equal-Weight | Lowers | 8.00 | 6.00 |
| 2022-08-03 | Goldman Sachs | Matthew Sykes | Maintains | Neutral | Lowers | 4.00 | 2.00 |
| 2022-07-14 | Goldman Sachs | Matthew Sykes | Maintains | Neutral | Lowers | 5.00 | 4.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| NAUT | Nautilus Biotechnology | -1.14% | 433.5M |
| HBIO | Harvard Bioscience | 0.49% | 175.9M |
| CDXS | Codexis | -5.29% | 112.4M |
| BLFS | BioLife Solns | 0.12% | 553M |
| OLK | Olink Holding | -0.68% | 1.8B |
How do I buy Nautilus Biotechnology (NAUT) stock?
You can purchase shares of Nautilus Biotechnology (NASDAQ: NAUT) through any online brokerage.
Who are Nautilus Biotechnology's (NAUT) competitors?
Other companies in Nautilus Biotechnology’s space includes: Harvard Bioscience (NASDAQ:HBIO), Codexis (NASDAQ:CDXS), BioLife Solns (NASDAQ:BLFS), Olink Holding (NASDAQ:OLK) and Quanterix (NASDAQ:QTRX).
What is the target price for Nautilus Biotechnology (NAUT) stock?
The latest price target for Nautilus Biotechnology (NASDAQ: NAUT) was reported by Morgan Stanley on Thursday, August 3, 2023. The analyst firm set a price target for 6.00 expecting NAUT to rise to within 12 months (a possible 72.91% upside). 1 analyst firms have reported ratings in the last year.
Current Stock Price for Nautilus Biotechnology (NAUT)?
The stock price for Nautilus Biotechnology (NASDAQ: NAUT) is $3.47 last updated Today at September 21, 2023 at 7:49 PM UTC.
Does Nautilus Biotechnology (NAUT) pay a dividend?
There is no dividend information for Nautilus Biotechnology.
When is Nautilus Biotechnology (NASDAQ:NAUT) reporting earnings?
Nautilus Biotechnology’s Q3 earnings are confirmed for Tuesday, October 31, 2023.
Is Nautilus Biotechnology (NAUT) going to split?
There is no upcoming split for Nautilus Biotechnology.
What sector and industry does Nautilus Biotechnology (NAUT) operate in?
Nautilus Biotechnology is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NASDAQ.
Nautilus Biotechnology Stock (NASDAQ:NAUT), Quotes and News Summary
Nautilus Biotechnology Stock (NASDAQ: NAUT) stock price, news, charts, stock research, profile.
| Open3.480 | Close- |
| Vol / Avg.43.900K / 104.815K | Mkt Cap433.510M |
| Day Range3.420 - 3.620 | 52 Wk Range1.500 - 4.650 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.170 | -0.130 | 0.0400 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-08-03 | Morgan Stanley | Tejas Savant | Reiterates | Equal-WeightEqual-Weight | Maintains | 6.00 | 6.00 |
| 2022-08-03 | Morgan Stanley | Tejas Savant | Maintains | Equal-Weight | Lowers | 8.00 | 6.00 |
| 2022-08-03 | Goldman Sachs | Matthew Sykes | Maintains | Neutral | Lowers | 4.00 | 2.00 |
| 2022-07-14 | Goldman Sachs | Matthew Sykes | Maintains | Neutral | Lowers | 5.00 | 4.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| NAUT | Nautilus Biotechnology | -1.14% | 433.5M |
| HBIO | Harvard Bioscience | 0.49% | 175.9M |
| CDXS | Codexis | -5.29% | 112.4M |
| BLFS | BioLife Solns | 0.12% | 553M |
| OLK | Olink Holding | -0.68% | 1.8B |
How do I buy Nautilus Biotechnology (NAUT) stock?
You can purchase shares of Nautilus Biotechnology (NASDAQ: NAUT) through any online brokerage.
Who are Nautilus Biotechnology's (NAUT) competitors?
Other companies in Nautilus Biotechnology’s space includes: Harvard Bioscience (NASDAQ:HBIO), Codexis (NASDAQ:CDXS), BioLife Solns (NASDAQ:BLFS), Olink Holding (NASDAQ:OLK) and Quanterix (NASDAQ:QTRX).
What is the target price for Nautilus Biotechnology (NAUT) stock?
The latest price target for Nautilus Biotechnology (NASDAQ: NAUT) was reported by Morgan Stanley on Thursday, August 3, 2023. The analyst firm set a price target for 6.00 expecting NAUT to rise to within 12 months (a possible 72.91% upside). 1 analyst firms have reported ratings in the last year.
Current Stock Price for Nautilus Biotechnology (NAUT)?
The stock price for Nautilus Biotechnology (NASDAQ: NAUT) is $3.47 last updated Today at September 21, 2023 at 7:49 PM UTC.
Does Nautilus Biotechnology (NAUT) pay a dividend?
There is no dividend information for Nautilus Biotechnology.
When is Nautilus Biotechnology (NASDAQ:NAUT) reporting earnings?
Nautilus Biotechnology’s Q3 earnings are confirmed for Tuesday, October 31, 2023.
Is Nautilus Biotechnology (NAUT) going to split?
There is no upcoming split for Nautilus Biotechnology.
What sector and industry does Nautilus Biotechnology (NAUT) operate in?
Nautilus Biotechnology is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NASDAQ.
Nautilus Biotechnology Stock (NASDAQ:NAUT), Quotes and News Summary
Nautilus Biotechnology Stock (NASDAQ: NAUT) stock price, news, charts, stock research, profile.
| Open3.480 | Close- |
| Vol / Avg.43.900K / 104.815K | Mkt Cap433.510M |
| Day Range3.420 - 3.620 | 52 Wk Range1.500 - 4.650 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.170 | -0.130 | 0.0400 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-08-03 | Morgan Stanley | Tejas Savant | Reiterates | Equal-WeightEqual-Weight | Maintains | 6.00 | 6.00 |
| 2022-08-03 | Morgan Stanley | Tejas Savant | Maintains | Equal-Weight | Lowers | 8.00 | 6.00 |
| 2022-08-03 | Goldman Sachs | Matthew Sykes | Maintains | Neutral | Lowers | 4.00 | 2.00 |
| 2022-07-14 | Goldman Sachs | Matthew Sykes | Maintains | Neutral | Lowers | 5.00 | 4.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| NAUT | Nautilus Biotechnology | -1.14% | 433.5M |
| HBIO | Harvard Bioscience | 0.49% | 175.9M |
| CDXS | Codexis | -5.29% | 112.4M |
| BLFS | BioLife Solns | 0.12% | 553M |
| OLK | Olink Holding | -0.68% | 1.8B |
How do I buy Nautilus Biotechnology (NAUT) stock?
You can purchase shares of Nautilus Biotechnology (NASDAQ: NAUT) through any online brokerage.
Who are Nautilus Biotechnology's (NAUT) competitors?
Other companies in Nautilus Biotechnology’s space includes: Harvard Bioscience (NASDAQ:HBIO), Codexis (NASDAQ:CDXS), BioLife Solns (NASDAQ:BLFS), Olink Holding (NASDAQ:OLK) and Quanterix (NASDAQ:QTRX).
What is the target price for Nautilus Biotechnology (NAUT) stock?
The latest price target for Nautilus Biotechnology (NASDAQ: NAUT) was reported by Morgan Stanley on Thursday, August 3, 2023. The analyst firm set a price target for 6.00 expecting NAUT to rise to within 12 months (a possible 72.91% upside). 1 analyst firms have reported ratings in the last year.
Current Stock Price for Nautilus Biotechnology (NAUT)?
The stock price for Nautilus Biotechnology (NASDAQ: NAUT) is $3.47 last updated Today at September 21, 2023 at 7:49 PM UTC.
Does Nautilus Biotechnology (NAUT) pay a dividend?
There is no dividend information for Nautilus Biotechnology.
When is Nautilus Biotechnology (NASDAQ:NAUT) reporting earnings?
Nautilus Biotechnology’s Q3 earnings are confirmed for Tuesday, October 31, 2023.
Is Nautilus Biotechnology (NAUT) going to split?
There is no upcoming split for Nautilus Biotechnology.
What sector and industry does Nautilus Biotechnology (NAUT) operate in?
Nautilus Biotechnology is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NASDAQ.
Nautilus Biotechnology Stock (NASDAQ:NAUT), Quotes and News Summary
Nautilus Biotechnology Stock (NASDAQ: NAUT) stock price, news, charts, stock research, profile.
| Open3.480 | Close- |
| Vol / Avg.43.900K / 104.815K | Mkt Cap433.510M |
| Day Range3.420 - 3.620 | 52 Wk Range1.500 - 4.650 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.170 | -0.130 | 0.0400 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-08-03 | Morgan Stanley | Tejas Savant | Reiterates | Equal-WeightEqual-Weight | Maintains | 6.00 | 6.00 |
| 2022-08-03 | Morgan Stanley | Tejas Savant | Maintains | Equal-Weight | Lowers | 8.00 | 6.00 |
| 2022-08-03 | Goldman Sachs | Matthew Sykes | Maintains | Neutral | Lowers | 4.00 | 2.00 |
| 2022-07-14 | Goldman Sachs | Matthew Sykes | Maintains | Neutral | Lowers | 5.00 | 4.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| NAUT | Nautilus Biotechnology | -1.14% | 433.5M |
| HBIO | Harvard Bioscience | 0.49% | 175.9M |
| CDXS | Codexis | -5.29% | 112.4M |
| BLFS | BioLife Solns | 0.12% | 553M |
| OLK | Olink Holding | -0.68% | 1.8B |
How do I buy Nautilus Biotechnology (NAUT) stock?
You can purchase shares of Nautilus Biotechnology (NASDAQ: NAUT) through any online brokerage.
Who are Nautilus Biotechnology's (NAUT) competitors?
Other companies in Nautilus Biotechnology’s space includes: Harvard Bioscience (NASDAQ:HBIO), Codexis (NASDAQ:CDXS), BioLife Solns (NASDAQ:BLFS), Olink Holding (NASDAQ:OLK) and Quanterix (NASDAQ:QTRX).
What is the target price for Nautilus Biotechnology (NAUT) stock?
The latest price target for Nautilus Biotechnology (NASDAQ: NAUT) was reported by Morgan Stanley on Thursday, August 3, 2023. The analyst firm set a price target for 6.00 expecting NAUT to rise to within 12 months (a possible 72.91% upside). 1 analyst firms have reported ratings in the last year.
Current Stock Price for Nautilus Biotechnology (NAUT)?
The stock price for Nautilus Biotechnology (NASDAQ: NAUT) is $3.47 last updated Today at September 21, 2023 at 7:49 PM UTC.
Does Nautilus Biotechnology (NAUT) pay a dividend?
There is no dividend information for Nautilus Biotechnology.
When is Nautilus Biotechnology (NASDAQ:NAUT) reporting earnings?
Nautilus Biotechnology’s Q3 earnings are confirmed for Tuesday, October 31, 2023.
Is Nautilus Biotechnology (NAUT) going to split?
There is no upcoming split for Nautilus Biotechnology.
What sector and industry does Nautilus Biotechnology (NAUT) operate in?
Nautilus Biotechnology is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NASDAQ.
Nautilus Biotechnology Stock (NASDAQ:NAUT), Quotes and News Summary
Nautilus Biotechnology Stock (NASDAQ: NAUT) stock price, news, charts, stock research, profile.
| Open3.480 | Close- |
| Vol / Avg.43.900K / 104.815K | Mkt Cap433.510M |
| Day Range3.420 - 3.620 | 52 Wk Range1.500 - 4.650 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.170 | -0.130 | 0.0400 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-08-03 | Morgan Stanley | Tejas Savant | Reiterates | Equal-WeightEqual-Weight | Maintains | 6.00 | 6.00 |
| 2022-08-03 | Morgan Stanley | Tejas Savant | Maintains | Equal-Weight | Lowers | 8.00 | 6.00 |
| 2022-08-03 | Goldman Sachs | Matthew Sykes | Maintains | Neutral | Lowers | 4.00 | 2.00 |
| 2022-07-14 | Goldman Sachs | Matthew Sykes | Maintains | Neutral | Lowers | 5.00 | 4.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| NAUT | Nautilus Biotechnology | -1.14% | 433.5M |
| HBIO | Harvard Bioscience | 0.49% | 175.9M |
| CDXS | Codexis | -5.29% | 112.4M |
| BLFS | BioLife Solns | 0.12% | 553M |
| OLK | Olink Holding | -0.68% | 1.8B |
How do I buy Nautilus Biotechnology (NAUT) stock?
You can purchase shares of Nautilus Biotechnology (NASDAQ: NAUT) through any online brokerage.
Who are Nautilus Biotechnology's (NAUT) competitors?
Other companies in Nautilus Biotechnology’s space includes: Harvard Bioscience (NASDAQ:HBIO), Codexis (NASDAQ:CDXS), BioLife Solns (NASDAQ:BLFS), Olink Holding (NASDAQ:OLK) and Quanterix (NASDAQ:QTRX).
What is the target price for Nautilus Biotechnology (NAUT) stock?
The latest price target for Nautilus Biotechnology (NASDAQ: NAUT) was reported by Morgan Stanley on Thursday, August 3, 2023. The analyst firm set a price target for 6.00 expecting NAUT to rise to within 12 months (a possible 72.91% upside). 1 analyst firms have reported ratings in the last year.
Current Stock Price for Nautilus Biotechnology (NAUT)?
The stock price for Nautilus Biotechnology (NASDAQ: NAUT) is $3.47 last updated Today at September 21, 2023 at 7:49 PM UTC.
Does Nautilus Biotechnology (NAUT) pay a dividend?
There is no dividend information for Nautilus Biotechnology.
When is Nautilus Biotechnology (NASDAQ:NAUT) reporting earnings?
Nautilus Biotechnology’s Q3 earnings are confirmed for Tuesday, October 31, 2023.
Is Nautilus Biotechnology (NAUT) going to split?
There is no upcoming split for Nautilus Biotechnology.
What sector and industry does Nautilus Biotechnology (NAUT) operate in?
Nautilus Biotechnology is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NASDAQ.
Nautilus Biotechnology Stock (NASDAQ:NAUT), Quotes and News Summary
Nautilus Biotechnology Stock (NASDAQ: NAUT) stock price, news, charts, stock research, profile.
| Open3.480 | Close- |
| Vol / Avg.43.900K / 104.815K | Mkt Cap433.510M |
| Day Range3.420 - 3.620 | 52 Wk Range1.500 - 4.650 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.170 | -0.130 | 0.0400 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-08-03 | Morgan Stanley | Tejas Savant | Reiterates | Equal-WeightEqual-Weight | Maintains | 6.00 | 6.00 |
| 2022-08-03 | Morgan Stanley | Tejas Savant | Maintains | Equal-Weight | Lowers | 8.00 | 6.00 |
| 2022-08-03 | Goldman Sachs | Matthew Sykes | Maintains | Neutral | Lowers | 4.00 | 2.00 |
| 2022-07-14 | Goldman Sachs | Matthew Sykes | Maintains | Neutral | Lowers | 5.00 | 4.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| NAUT | Nautilus Biotechnology | -1.14% | 433.5M |
| HBIO | Harvard Bioscience | 0.49% | 175.9M |
| CDXS | Codexis | -5.29% | 112.4M |
| BLFS | BioLife Solns | 0.12% | 553M |
| OLK | Olink Holding | -0.68% | 1.8B |
How do I buy Nautilus Biotechnology (NAUT) stock?
You can purchase shares of Nautilus Biotechnology (NASDAQ: NAUT) through any online brokerage.
Who are Nautilus Biotechnology's (NAUT) competitors?
Other companies in Nautilus Biotechnology’s space includes: Harvard Bioscience (NASDAQ:HBIO), Codexis (NASDAQ:CDXS), BioLife Solns (NASDAQ:BLFS), Olink Holding (NASDAQ:OLK) and Quanterix (NASDAQ:QTRX).
What is the target price for Nautilus Biotechnology (NAUT) stock?
The latest price target for Nautilus Biotechnology (NASDAQ: NAUT) was reported by Morgan Stanley on Thursday, August 3, 2023. The analyst firm set a price target for 6.00 expecting NAUT to rise to within 12 months (a possible 72.91% upside). 1 analyst firms have reported ratings in the last year.
Current Stock Price for Nautilus Biotechnology (NAUT)?
The stock price for Nautilus Biotechnology (NASDAQ: NAUT) is $3.47 last updated Today at September 21, 2023 at 7:49 PM UTC.
Does Nautilus Biotechnology (NAUT) pay a dividend?
There is no dividend information for Nautilus Biotechnology.
When is Nautilus Biotechnology (NASDAQ:NAUT) reporting earnings?
Nautilus Biotechnology’s Q3 earnings are confirmed for Tuesday, October 31, 2023.
Is Nautilus Biotechnology (NAUT) going to split?
There is no upcoming split for Nautilus Biotechnology.
What sector and industry does Nautilus Biotechnology (NAUT) operate in?
Nautilus Biotechnology is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NASDAQ.